108 related articles for article (PubMed ID: 3180306)
1. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
Cruciani M; Navarra A; Bono L; Concia E
Chemioterapia; 1988 Aug; 7(4):261-3. PubMed ID: 3180306
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
Cruciani M; Navarra A; Bono L; Concia E
J Chemother; 1989 Jul; 1(4 Suppl):101-2. PubMed ID: 16312323
[No Abstract] [Full Text] [Related]
3. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.
Stein GE; Schooley S; Tyrrell KL; Citron DM; Nicolau DP; Goldstein EJ
Anaerobe; 2008 Feb; 14(1):8-12. PubMed ID: 17983770
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
[No Abstract] [Full Text] [Related]
5. In vitro antibacterial activity of cefoxitin and cefotetan and pharmacokinetics in dogs.
Petersen SW; Rosin E
Am J Vet Res; 1993 Sep; 54(9):1496-9. PubMed ID: 8239139
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
Edmiston CE; Krepel CJ; Clausz JC; Condon RE
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):105-13. PubMed ID: 3164263
[TBL] [Abstract][Full Text] [Related]
7. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
Aldridge KE
Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
Grossmeyer TJ; Farmer SG
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
[No Abstract] [Full Text] [Related]
10. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
Aldridge KE; Weeks LS; Stratton CW; Sanders CV
Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
[TBL] [Abstract][Full Text] [Related]
11. Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
Goldstein EJ; Citron DM; Merriam CV; Abramson MA
Surg Infect (Larchmt); 2009 Apr; 10(2):111-8. PubMed ID: 19226203
[TBL] [Abstract][Full Text] [Related]
12. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Michalska W; Chylak J; Pietkiewicz K
Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers.
Carver PL; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1989 Jan; 23(1):99-106. PubMed ID: 2745258
[TBL] [Abstract][Full Text] [Related]
17. Bacteriology of acute appendicitis with special reference to anaerobes.
Jindal N; Kaur GD; Arora S; Rajiv
Indian J Pathol Microbiol; 1994 Jul; 37(3):299-305. PubMed ID: 7814062
[TBL] [Abstract][Full Text] [Related]
18. Post-antibiotic effect in Bacteroides fragilis group.
Siverhus DJ; Edmiston CE; Clausz JC; Goheen MP
Ann Clin Lab Sci; 1988; 18(4):326-36. PubMed ID: 3165611
[TBL] [Abstract][Full Text] [Related]
19. Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
J Chemother; 1989 Jul; 1(4 Suppl):825-7. PubMed ID: 16312657
[No Abstract] [Full Text] [Related]
20. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
